Vanrafia 0.75 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB26FJVPZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,131
Award facts
- Contract value 100% obligated
- $9,130.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Vanrafia 0.75 mg tablets in 30-count units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $9,130.88 and is scheduled for completion by November 10, 2025. The contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a wide range of medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's extensive portfolio of federal contracts with the DLA Medical Supply Chain encompasses diverse pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The delivery of Vanrafia under this order supports the company's ongoing role as a key supplier within the DLA's pharmaceutical procurement strategy, which is evolving toward the Pharmaceutical Prime Vendor Global Program Generation V model with planned multiple awards across separate regions.
Quick answers
Who was awarded contract SPE2DB26FJVPZ?
SPE2DB26FJVPZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DB26FJVPZ worth?
The government has obligated $9,131 on SPE2DB26FJVPZ.
Is contract SPE2DB26FJVPZ an order under another contract?
Yes. SPE2DB26FJVPZ is a delivery order under SPE2DB24D2217, an indefinite delivery contract.
Was contract SPE2DB26FJVPZ competed?
The extent of competition for SPE2DB26FJVPZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award